daunorubicin has been researched along with Carcinoma, Krebs 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottikh, MB; Krynetskaya, NF; Shabarova, ZA | 1 |
1 other study(ies) available for daunorubicin and Carcinoma, Krebs 2
| Article | Year |
|---|---|
Oligonucleotide derivatives resistant to the cell nuclease degradation and effective for the RNA hydrolysis by RNase H.
Topics: Animals; Carcinoma, Krebs 2; Daunorubicin; Escherichia coli; Ethidium; Ethylenediamines; Indicators and Reagents; Mice; Oligonucleotides; Ribonuclease H; Ribonucleases; RNA; RNA, Ribosomal, 5S; Substrate Specificity | 1991 |